Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#279 most reported symptom for this vaccine
Recalled product administered has been reported 124 times in association with Hepatitis B (Engerix-B) vaccination in VAERS. This represents 0.2% of all 73,280 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 0 involved hospitalization (0.0%).
Recalled product administered is the #279 most frequently reported symptom for Hepatitis B (Engerix-B) out of 2382 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 124 reports of Recalled product administered after Hepatitis B (Engerix-B) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.